Design
BPSD
SECONDARY
HOMESIDE is a large international pragmatic, three-arm parallel-group RCT. Dyads consisting of the PwD and cohabitating CG were randomised to one of the three arms: MI plus SC, RI plus SC or SC alone. HOMESIDE is a superiority trial, with the hypothesis that MI plus SC is superior to SC alone (primary) and RI plus SC (secondary) in relation to BPSD at 90 days post-randomisation. Online assessments occurred at each MI/RI instruction session and follow-up at 90 and 180 days post-randomisation (Fig. HOMESIDE illustration of study design